Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Crossing curves, uncertain effects: Spironolactone in heart failure with preserved ejection fraction after myocardial infarction. Local targets link to admitted publications; unresolved targets remain external evidence.
Efficacy of spironolactone in patients with heart failure with preserved ejection fraction following acute myocardial infarction: a multicenter retrospective cohort analysis
10.1016/j.amjmed.2026.03.049 · 2026 · External reference
Uses and limitations of the restricted mean survival time: illustrative examples from cardiovascular outcomes and mortality trials in Type 2 Diabetes
10.7326/m19-3286 · 2020 · External reference
Nonproportional hazards for time-to-event outcomes in clinical trials: JACC review topic of the week
10.1016/j.jacc.2019.08.1034 · 2019 · External reference
Spironolactone for heart failure with preserved ejection fraction
10.1056/nejmoa1313731 · 2014 · External reference
Routine spironolactone in acute myocardial infarction
10.1056/nejmoa2405923 · 2025 · External reference
